Company profile: CITrials
1.1 - Company Overview
Company description
- Provider of pharmaceutical medical research conducting clinical trials across Phase I-IV to evaluate safety, efficacy, dosing, and long-term effectiveness of investigational and approved drugs. Offers studies in mental health conditions, including depression, anxiety, bipolar disorder, and schizophrenia, and women's health, including reproductive health and other gender-specific conditions.
Products and services
- Phase III Clinical Trials: Large-scale studies confirming safety and efficacy of investigational drugs in the intended patient population before market approval
- Phase II Clinical Trials: Mid-phase studies involving a larger group of patients to determine safety, efficacy, and optimal dosage range of investigational drugs
- Phase I Clinical Trials: Early-phase trials with a small group of healthy volunteers to determine safety, metabolism, and pharmacologic actions of investigational drugs
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to CITrials
Beghou Consulting
HQ: United States
Website
- Description: Provider of management consulting, data solutions, and advanced analytics for life sciences companies, serving the US and India. Services span commercial operations improvement, sales force design, segmentation and targeting, incentive compensation design and administration, forecasting, omnichannel orchestration, and data collection/integration with advanced analytics including machine learning.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Beghou Consulting company profile →
Oncodesign
HQ: France
Website
- Description: Provider of precision medicine-driven oncology preclinical CRO services and biopharmaceutical R&D, developing anticancer therapies and leveraging platforms such as Nanocyclix for selective kinase inhibitors and OncoSNIPER AI for resistant patient stratification. Pipeline includes OPM-101 (RIPK2, IBD), OPM-102 (RIPK2, inflammation-related tumors), and an LRRK2 program (Parkinson’s), plus the IMODI cluster for cancer models and microbiota studies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Oncodesign company profile →
Herbamed
HQ: Switzerland
Website
- Description: Provider of homeopathy, drugs, veterinary medicines, and documentation services, as a manufacturing company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Herbamed company profile →
Southwood Research
HQ: United Kingdom
Website
- Description: Provider of pre-approval regulatory science services to the pharmaceutical and biotech industries, focusing on the science behind each product and delivering strategic clinical and regulatory insight.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Southwood Research company profile →
Continuus Pharmaceuticals
HQ: United States
Website
- Description: Provider of Build-Own-Operate integrated continuous manufacturing solutions for small molecule pharmaceuticals, designing, building, and running client-site processes. Offerings include end-to-end ICM pilot plants, continuous reactive crystallization, solvent recovery systems, EMC for oral solid dosage forms, and automated modular assembly lines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Continuus Pharmaceuticals company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for CITrials
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to CITrials
2.2 - Growth funds investing in similar companies to CITrials
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for CITrials
4.2 - Public trading comparable groups for CITrials
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →